Advertisement

Journal of Gastroenterology

, Volume 54, Issue 2, pp 204–205 | Cite as

Advanced assessment of serum Mac-2 binding protein glycosylation isomer in patients with biliary atresia

  • Naoya YamadaEmail author
  • Koichi Mizuta
Letter to the Editor
  • 160 Downloads

Abbreviations

M2BPGi

Mac-2 Biding Protein Glycosylation isomer

BA

Biliary atresia

LT

Liver transplantation

GI

Gastrointestinal

COI

Cut off index

HSCs

Hepatic stellate cells

Notes

Funding

No financial support was provided for this work.

Compliance with ethical standards

Conflict of interest

The authors declare that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Written informed consent was obtained from the patient’s family demonstrated in this letter.

References

  1. 1.
    Shirabe K, Bekki Y, Gantumur D, et al. Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. J Gastroenterol. 2018;53:819–26.CrossRefGoogle Scholar
  2. 2.
    Yamada N, Sanada Y, Tashiro M, et al. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. J Gastroenterol. 2017;52:245–52.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2018

Authors and Affiliations

  1. 1.Department of Transplant SurgeryJichi Medical UniversityShimotsukeJapan

Personalised recommendations